Serologic markers of epstein-barr virus infection and nasopharyngeal carcinoma in taiwanese men

New England Journal of Medicine

Volumn 345, Issue 26, 2001, Pages 1877-1882

  Chien, Yin Chu ^a   Chen, Jen Yang ^b   Liu, Mei Ying ^d   Yang, Hwai I ^a   Hsu, Mow Ming ^c   Chen, Chien Jen ^a   Yang, Czau Siung ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Graduate Institute of Microbiology   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DEOXYRIBONUCLEASE; IMMUNOGLOBULIN A; VIRUS ANTIBODY;

ARTICLE; BLOOD; COHORT ANALYSIS; EPSTEIN BARR VIRUS; FOLLOW UP; HUMAN; IMMUNOLOGY; INCIDENCE; LIFE TABLE; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNX TUMOR; RISK FACTOR; TAIWAN; VIRUS CAPSID; VIRUS INFECTION;

ANTIBODIES; ANTIBODIES, VIRAL; CAPSID; COHORT STUDIES; DEOXYRIBONUCLEASES; EPSTEIN-BARR VIRUS INFECTIONS; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMAN; IMMUNOGLOBULIN A; INCIDENCE; LIFE TABLES; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; TAIWAN;

EID: 0035960862     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa011610     Document Type: Article

References (19)

1. Yu MC, Henderson BE. Nasopharyngeal cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press, 1996:603-18.
2. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 70. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon, France: IARC Press, 1997:47-373.
3. Old LJ, Boyse EA, Oettgen HP. Precipitating antibody in human serum to antigen present in cultured Burkitt lymphoma cell. Proc Natl Acad Sci U S A 1966;56:1699-704.
4. Henle W, Henle G, Ho HC, et al. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and control groups. J Natl Cancer Inst 1970;44:225-31.
5. de-The G, Ho JHC, Ablashi DV, et al. Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other EBV antigens in Chinese patients. Int J Cancer 1975;16:713-21.
6. Wara WM, Wara DW, Phillips TL, Ammann AJ. Elevated IgA in carcinoma of the nasopharynx. Cancer 1975;35:1313-5.
7. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976;17:1-7.
8. Chen CJ, You SL, Pan WH, et al. Seroepidemiology of Epstein-Barr virus and cytomegalovirus infection among preschool and school children in Taiwan. Chin J Microbiol Immunol 1991;24:150-8.
9. Chen JY, Chen CJ, Liu MY, et al. Antibodies to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma and control group. J Med Virol 1987;23:11-21.
10. Chen JY, Chen CJ, Liu MY, et al. Antibody to Epstein-Barr virus specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. J Med Virol 1989;27:269-73.
11. Hildesheim A, Levine PH. Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev 1993;15:466-85.
12. Jeannel D, Bouvier G, Hubert A. Nasopharyngeal cancer: an epidemiological approach to carcinogenesis. In: Newton R, Beral V, Weiss RA, eds. Infections and human cancer. Plainview, N.Y.: Cold Spring Harbor Laboratory Press, 1999:125-55.
13. Zeng Y, Zhang LG, Li HY, et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 1982;29:139-41.
14. Zeng Y, Zhong JM, Li LY, et al. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China. Intervirology 1983;20:190-4.
15. Zeng Y, Zhang LG, Wu YC, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer 1985;36:545-7.
16. Lin YH, Chen CJ. A cohort study on multiple risk factors of nasopharyngeal carcinoma. Chinese J Public Health (Taipei) 1997;16:466-77.
17. Zong YS, Sham JS, Ng MH, et al. Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharyngeal carcinoma in the detection of asymptomatic nasopharyngeal carcinoma. Cancer 1992;69:3-7.
18. Chen KP, Wu HY, Yeh CC, Cheng YJ. Color atlas of cancer mortality by administrative and other classified districts in Taiwan area: 1968-1976. Taipei, Taiwan: National Science Council, 1979.
19. Liu MY, Chang YL, Ma J, et al. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma. J Med Virol 1997;52:262-9.